OSCR

Regulatory BC200 RNA promotes breast carcinogenesis by repressing BRCA1 gene expression.

Overview

Authors: Valerio Berardi1, Ilham A. Muslimov1, Dan Sun2, Giuseppe Militello2, Prem Premsrirut2,3, Henri Tiedge1,4,5
ORCID iDs: Dan Sun
  1. Department of Physiology and Pharmacology, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA
  2. Mirimus Inc., Brooklyn, NY 11226, USA
  3. Department of Cell Biology, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA
  4. Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA
  5. Department of Neurology, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA
Institutions: SUNY Downstate Health Sciences University (United States)
Journal: iScience, volume 29, issue 4, article 115267
Dates: received 3 July 2025; accepted 3 March 2026; published online 6 March 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1016/j.isci.2026.115267 · PMID 41907432 · PMCID PMC13018867 · OpenAlex W7134132623
Open access: gold, a free copy (OpenAlex)
Status: code on request
Categories: other condition (population), cellular / molecular (subfield)
Methods: Statistics, Evoked potentials
Keywords: Biological sciences, Molecular mechanism of gene regulation, Cancer systems biology, Cancer
Topic: BRCA gene mutations in cancer (Genetics, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: Scientific Computing Center; SUNY Downstate Health Sciences University; NIH (NS046769); Technology Accelerator Fund; Research Foundation for SUNY
Citations: not cited yet (Europe PMC); 61 references in the paper
Research resources: γ-Tubulin RRID:AB_10836184, Retinoblastoma RRID:AB_1904119, BRCA1 RRID:AB_2228244, EGFP-BRCA1 RRID:Addgene_115491, MCF-7 cells RRID:CVCL_0031, MCF-10A cells RRID:CVCL_0598, SUM229PE cells RRID:CVCL_5594

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Code and data availability statement

The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it says that the data are available on request
  • it says that the code is available on request

Read it in the paper: doi.org/10.1016/j.isci.2026.115267.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 4 keywords, 5 funders, 60 references, 7 RRIDs.

Cite

This paper

Berardi, V., Muslimov, I. A., Sun, D., Militello, G., Premsrirut, P., & Tiedge, H. (2026). Regulatory BC200 RNA promotes breast carcinogenesis by repressing BRCA1 gene expression. iScience, 29(4), 115267. https://doi.org/10.1016/j.isci.2026.115267

BibTeX

@article{berardi2026regulatory,
author = {Berardi, Valerio and Muslimov, Ilham A. and Sun, Dan and Militello, Giuseppe and Premsrirut, Prem and Tiedge, Henri},
title = {{Regulatory BC200 RNA promotes breast carcinogenesis by repressing BRCA1 gene expression}},
journal = {iScience},
year = {2026},
month = mar,
volume = {29},
number = {4},
pages = {115267},
publisher = {Elsevier},
issn = {2589-0042},
doi = {10.1016/j.isci.2026.115267},
url = {https://doi.org/10.1016/j.isci.2026.115267},
pmid = {41907432},
pmcid = {PMC13018867}
}

RIS

TY - JOUR
AU - Berardi, Valerio
AU - Muslimov, Ilham A.
AU - Sun, Dan
AU - Militello, Giuseppe
AU - Premsrirut, Prem
AU - Tiedge, Henri
TI - Regulatory BC200 RNA promotes breast carcinogenesis by repressing BRCA1 gene expression
T2 - iScience
J2 - iScience
PY - 2026
DA - 2026/03/06
VL - 29
IS - 4
SP - 115267
SN - 2589-0042
PB - Elsevier
DO - 10.1016/j.isci.2026.115267
UR - https://doi.org/10.1016/j.isci.2026.115267
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.isci.2026.115267",
"type": "article-journal",
"title": "Regulatory BC200 RNA promotes breast carcinogenesis by repressing BRCA1 gene expression",
"container-title": "iScience",
"author": [
{
"family": "Berardi",
"given": "Valerio"
},
{
"family": "Muslimov",
"given": "Ilham A."
},
{
"family": "Sun",
"given": "Dan"
},
{
"family": "Militello",
"given": "Giuseppe"
},
{
"family": "Premsrirut",
"given": "Prem"
},
{
"family": "Tiedge",
"given": "Henri"
}
],
"container-title-short": "iScience",
"volume": "29",
"issue": "4",
"page": "115267",
"DOI": "10.1016/j.isci.2026.115267",
"PMID": "41907432",
"PMCID": "PMC13018867",
"ISSN": "2589-0042",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.isci.2026.115267",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
6
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s13020-026-01445-6
Electroacupuncture enhances anti-tumor immunity in TNBC by reducing NE release and blocking α2-AR-mediated NGF/Hippo signaling.
Journal: Chinese medicine
In common: other condition, cellular / molecular, 2 references
[2] doi:10.1038/s41467-026-77302-9 [code]
Identification and validation of central amygdala FGFR1 as a therapeutic target for alcohol use disorder using single-nucleus sequencing in rats.
Journal: Nature communications
In common: other condition, cellular / molecular, 1 reference
[3] doi:10.1186/s40478-026-02312-z
Dissecting acute neuronal responses to glioblastoma using a dual-interface human iPSC neuronal culture platform.
Journal: Acta neuropathologica communications
In common: other condition, cellular / molecular, 1 reference
[4] doi:10.1016/j.cell.2026.05.047 [code]
An emergent disease-associated motor neuron state precedes cell death in ALS.
Journal: Cell
In common: other condition, cellular / molecular, 1 reference
[5] doi:10.1093/narmme/ugag028 [code]
MCVAE-based multi-omic anomaly detection in Fragile X Syndrome.
Journal: NAR molecular medicine
In common: other condition, cellular / molecular, 1 reference
[6] doi:10.1038/s41392-026-02648-x
Prostaglandin E<sub>2</sub>-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarcinoma.
Journal: Signal transduction and targeted therapy
In common: other condition, cellular / molecular, 1 reference
[7] doi:10.1158/0008-5472.can-25-2237 [code]
Extracellular Vesicle-Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion.
Journal: Cancer research
In common: other condition, cellular / molecular, 1 reference
[8] doi:10.1126/sciadv.aeb1237
Magnetically actuated nanoantennas for wireless glioblastoma therapy.
Journal: Science advances
In common: other condition, 1 reference
[9] doi:10.1002/cam4.72199
Evaluation of the Expression and Prognosis of Neural-Related Products Expressed by Cancer-Derived Mesenchymal Stem Cells With the Characteristics of Neural Stem Cells.
Journal: Cancer medicine
In common: other condition, 1 reference
[10] doi:10.1186/s13073-026-01650-w [code]
DNA methylation biomarkers-based pan-cancer classifier: predictive modeling for cancer classification.
Journal: Genome medicine
In common: other condition, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.